Literature DB >> 19875336

Cetuximab and panitumumab: are they interchangeable?

Richard Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19875336     DOI： 10.1016/S1470-2045(09)70312-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

Review 1.  Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinoma.

Authors:  Bhaskar Bhardwaj; Swaroop Revannasiddaiah; Himanshu Bhardwaj; Sree Balusu; Ali Shwaiki
Journal:  Ann Transl Med       Date:  2016-02

Review 2.  Panitumumab: an arrow on target.

Authors:  László Kopper
Journal:  Pathol Oncol Res       Date:  2010-04-30       Impact factor: 3.201

3.  Alternate dosing of cetuximab for patients with metastatic colorectal cancer.

Authors:  Joleen M Hubbard; Steven R Alberts
Journal:  Gastrointest Cancer Res       Date:  2013-03

Review 4.  Emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Christopher Fung; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 5.  Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Authors:  Louis M Weiner; Rishi Surana; Shangzi Wang
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 6.  Mechanisms of action of therapeutic antibodies for cancer.

Authors:  J M Redman; E M Hill; D AlDeghaither; L M Weiner
Journal:  Mol Immunol       Date:  2015-04-23       Impact factor: 4.407

Review 7.  Harnessing the immune system to improve cancer therapy.

Authors:  Nikos E Papaioannou; Ourania V Beniata; Panagiotis Vitsos; Ourania Tsitsilonis; Pinelopi Samara
Journal:  Ann Transl Med       Date:  2016-07

8.  A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases.

Authors:  Kobe Van Bael; Yanina Jansen; Teofila Seremet; Benedikt Engels; Georges Delvaux; Bart Neyns
Journal:  Case Rep Oncol Med       Date:  2015-05-06

9.  IgA EGFR antibodies mediate tumour killing in vivo.

Authors:  Peter Boross; Stefan Lohse; Maaike Nederend; Johannes Hendrik Marco Jansen; Geert van Tetering; Michael Dechant; Matthias Peipp; Louise Royle; Li Phing Liew; Louis Boon; Nico van Rooijen; Wim K Bleeker; Paul W H I Parren; Jan G J van de Winkel; Thomas Valerius; Jeanette H W Leusen
Journal:  EMBO Mol Med       Date:  2013-08       Impact factor: 12.137
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.